Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Hy - Complete Pharm
Hy - Complete Pharm - One-Liners
| Question | Answer |
|---|---|
| NSAID contraindicated in gout | Aspirin |
| The selective agents loose their selectivity at | high doses |
| Scabicide organophosphate | Malathion |
| Common side effect of hypnotic agents | Sedation |
| Anti-seizure medication also used in the prevention of migraines | Valproic acid |
| Another pneumonic for anticholinergic toxicity | "dry as a bone, red as a beet, mad as a hatter, hot as a hare, blind as a bat" |
| Clinical response that may fluctuate in tx of Parkinson's dx | "On-off-phenomenon" |
| Antidote used for carbon monoxide poisoning | 100% O2 and hyperbaric O2 |
| Usual time needed for full effect of antidepressant therapy | 2 to 3 weeks |
| Period of time of therapy after which GC therapy will need to be tapered | 5-7 days |
| Pyrimidine analog that causes "Thiamine-less death" given with leucovorin rescue | 5-flouracil (5-FU) |
| Analog of hypoxanthine, needs HGPRTase for activation | 6-mercaptopurine (6-MP) |
| Block glycoprotein IIb/IIIa involved in platelet cross-linking | Abciximab, tirofiban and eptifibatide |
| Reason benzos are used cautiously in pregnancy | Ability to cross the placenta |
| Lacrimation, rhinorrhea, yawning, sweating, weakness, gooseflesh, nausea, and vomiting, tremor, muscle jerks, and hyperpnea are signs of this syndrome | Abstinence syndrome |
| Alpha-glucosidase inhibitor associated with elevation of LFT's | Acarbose |
| Examples of alpha-glucosidase inhibitors (AGI) | Acarbose, miglitol |
| Inhibit angiotensin-converting enzyme (ACE) | Ace inhibitors |
| Captopril and enalapril (-OPRIL ending) are | Ace inhibitors |
| These beta blockers are less lipid soluble | Acebutolol and atenolol |
| SelectiveB1 Receptor blockers that may be useful in treating patients with asthma | Acebutolol, atenolol, esmolol, metoprolol |
| This diuretic decreases aqueous secretion due to lack of HCO3- ion. Causes drowsiness and paresthesias, alkalinization of the urine may precipitate calcium salts, hypokalemia, acidosis | Acetazolamide |
| Diuretic used for mountain sickness and glaucoma | Acetazolamide |
| Carbonic anhydrase inhibitor | Acetazolamide |
| Clinical use for H2 blockers | Acid reflux disease, duodenal ulcer and peptic ulcer disease |
| MOA of AGI's | Act on intestine, delay absorption of glucose |
| Adenosine's MOA | Activates acetylcholine sensitive K+ channels in SA and AV node |
| Barbiturates may precipitate this hematologic condition | Acute intermittent porphyria |
| DOC for herpes and its MOA | Acyclovir and inhibits thymidine kinase Acyclovir and inhibits thymidine kinase |
| The most common type of drug interaction of sedative hypnotics with other depressant medications | Additive CNS depression |
| DOC for paroxysmal supraventricular tachycardia (PSVT) | Adenosine |
| Anti-arrhythmic with 15 second duration of action | Adenosine |
| Neurotoxicity with isoniazid (INH) prevented by | Administration of Vit. B6 (pyridoxine) |
| SE of long term (>5 days) corticosteroid therapy and remedy | Adrenal suppression and weaning slowly, respectively |
| ABVD regimen used for HD, but appears less likely to cause sterility and secondary malignancies than MOPP | Adriamycin (doxorubicin) +bleomycin, vinblastine +dacarbazine |
| MOA for Valproic acid at high doses | Affect calcium, potassium, and sodium channels |
| Strength of interaction between drug and its receptor | Affinity |
| Carbamazepine may cause | Agranulocytosis |
| Short acting Beta 2 agonists that is drug of choice in treatment of acute asthma but not recommended for prophylaxis | Albuterol |
| Agent that is teratogen and causes a fetal syndrome | Alcohol |
| Agent that is the antidote for methanol overdose | Alcohol |
| Rate limiting step of alcohol metabolism | Aldehyde dehydrogenase |
| Agent that metabolize acetaldehyde to acetate | Aldehyde dehydrogenase |
| Available bisphosphonates | Alendronate, etidronate, risedronate, pamidronate, tiludronate, and zoledronic acid |
| Antidote for salicylate intoxication | Alkalinize urine, dialysis |
| MOA of cisplatin | Alkylating agent |
| Some cell cycle non-specific drugs | Alkylating agents (eg., mechlorethamine, cyclophosphamide), antibiotics (doxorubicin, daunorubicin), cisplatin, nitrosourea |
| Drug used concurrently with toxic anticancer agents to reduce renal precipitation of urates | Allopurinol |
| Interaction with this drug requires dose reduction of 6-MP | Allopurinol |
| These agents decrease blood flow or increase blood pressure, are local decongestant, and used in therapy of spinal shock (temporary maintenance of blood pressure which may help maintain perfusion | Alpha1 agonists |
| Benzodiazepines that are the most effective in the treatment of panic disorder | Alprazolam and Clonazepam |
| Prostaglandin used in the treatment impotence | Alprostadil |
| MOA of gold salts | Alter activity of macrophages and suppress phagocytic activity of PMNs |
| DOC for influenza A | Amantadine |
| Enhances dopaminergic neurotransmission SE's include CNS excitation, acute toxic psychosis and livedo reticularis | Amantadine |
| Antidote for tissue plasminogen activator (t-PA), streptokinase | Aminocaproic acid |
| Antidote for thrombolytics | Aminocaproic acid |
| Inhibits conversion of cholesterol to pregnenolone therefore inhibiting corticosteroid synthesis | Aminoglutethimide |
| Class III antiarrhythmic that exhibits properties of all 4 classes | Amiodarone |
| Antiarrhythmic effective in most types of arrhythmia | Amiodarone |
| TCA used in chronic pain, a hypnotic, and has marked antimuscarinic effects | Amitriptyline |
| Antidepressant associated with neuroleptic malignant syndrome | Amoxapine |
| Cheap wide spectrum antibiotic DOC of otitis media | Amoxicillin |
| Phenylisopropylamines that are used legitimately and abused for narcolepsy, attention deficit disorder, and weight reduction | Amphetamines |
| Tolerance is marked and abstinence syndrome occurs | Amphetamines |
| Phosphodiesterase inhibitors that increase mortality and have been found to have NO beneficial effects | Amrinone and milrinone |
| Losartan and valsartan block | Angiotensin receptor |
| Neurologic SE of benzodiazepines | Anterograde amnesia |
| Four main actions of NSAIDS | Anti-inflammatory, analgesia, antipyretic and antiplatelet activity |
| Acetaminophen only has | Antipyretic and analgesic activity |
| Heparin (PTT) increases activity of | Antithrombin 3 |
| SE for Felbamate | Aplastic anemia and acute hepatic failure |
| SE of phenylbutazone | Aplastic anemia and agranulocytosis |
| SE of penicillamine | Aplastic anemia and renal |
| Selective alpha agonists that decreases aqueous secretion | Apraclonidine, brimonidine |
| Primary endogenous substrate for Nitric Oxidase Synthase | Arginine |
| Nitroprusside vasodilates | Arteries and veins |
| Inhibit synaptic activity of primary afferents and spinal cord pain transmission neurons | Ascending pathways |
| Irreversible, nonselective COX inhibitor | Aspirin |
| Agent used to treat MI and to reduce incidence of subsequent MI | Aspirin |
| Cutaneous flush and be reduced by pretreatment with | Aspirin |
| Difference between aspirin and other NSAIDS | Aspirin irreversibly inhibits cyclooxygenase |
| Drugs used in the management of angina | Aspirin, Nitrates, CCB, and Beta blockers |
| Beta-blockers should be used cautiously in | Asthma (bronchospastic effects), diabetes (block signs of hypoglycemia) and peripheral vascular disease |
| Cardioselective Beta 1-blockers | Atenolol, acebutolol, and metoprolol |
| Agent undergoing Hofmann elimination (breaking down spontaneously) | Atracurium |
| Digoxin is used in | Atrial fibrillation and CHF |
| Treatment of choice for organophosphate overdose | Atropine |
| Produce mydriasis and cycloplegia | Atropine, homatropine tropicamide |
| Antidote used for organophosphate/anticholinesterase poisoning | Atropine, pralidoxime (2-PAM) |
| Endogenous substances commonly interpreted as histamine, serotonin, prostaglandins, and vasoactive peptides | Autocoids |
| HIV med used to reduce transmission during birth | AZT (zidovudine) |
| Lactam that can be used in PCN allergic patients | Aztreonam |
| GABA agonist in the spinal cord | Baclofen |
| Inducers of Cytochrome P450 (CYP450) | Barbiturates, phenytoin, carbamazepine, and rifampin |
| Class II antiarrhythmics are | B-blockers |
| Anti-arrhythmics that decrease mortality | B-blockers |
| Site of action for zaleplon and zolpidem | Benzodiazepine receptor BZ1 (although are not considered benzodiazepines) |
| MOA utilizes ligand gated ion channels | Benzodiazepines and calcium channel blockers |
| Agent decreases the excitatory actions of cholinergic neurons. May improve tremor and rigidity but have LITTLE effect on bradykinesia. Atropine-like side effects | Benztropine |
| Treat manifestations of Parkinson's disease and EPS | Benztropine, trihexyphenidyl |
| Antidote for severe CV toxicity of theophylline | Beta blockers |
| Clinical uses of these agents include treatment of HTN, angina, arrhythmias, and chronic CHF | Beta blockers |
| Toxicity of these agents include bradycardia, AV blockade, exacerbation of acute CHF, signs of hypoglycemia may be masked (tachycardia, tremor, and anxiety) | Beta blockers |
| B-blockers that are more cardioselective | Beta C2001-selective blockers |
| These agents increase blood flow and may be beneficial in treatment of acute heart failure and some types of shock | Beta1 agonists |
| Reduce heart rate, contractility, and O2 demand | Beta-blockers |
| Block cardiac adverse effects of thyrotoxicosis such as tachycardia, inhibits the conversion of T4 to T3 | Beta-blockers such as propranolol |
| Long acting GC's | Betamethasone, dexamethasone, and paramethasone |
| This agent has greater affinity for muscarinic receptors and used for postoperative and neurogenic ileus and urinary retention | Bethanechol |
| Decrease intestinal absorption of cholesterol | Bile acid-binding resins |
| Cholestyramine and colestipol are | Bile acid-binding resins |
| MOA of nystatin | Bind ergosterol in fungal cell membrane |
| The fraction of administered dose of a drug that reaches systemic circulation | Bioavailability (F) |
| SE of both warfarin and heparin | Bleeding |
| Blows DNA (breaks DNA strands), limiting SE is pulmonary fibrosis | Bleomycin |
| Some cell cycle specific anti-cancer drugs | Bleomycin, vinca alkaloids, antimetabolites (eg., 5-FU, 6-MP, methotrexate, etoposide) |
| MOA of penicillin | Block cell wall synthesis by inhibiting peptidoglycan cross-linkage |
| Toxicity of anticholinergics | block SLUD (salivation, lacrimation, urination, defecation |
| MOA of local anesthetics (LA's) | Block voltage-dependent sodium channels |
| Vancomycin MOA | Blocks peptidoglycan synthesis |
| SE of demeclocycline | Bone marrow and teeth discoloration for children under 8 years of age |
| SE of beta blockers | Bradycardia, SEXUAL DYSFUNCTION, decrease in HDL, and increase in Triglycerols (TG) |
| Mediator of tissue pain, edema, inactivated by ACE, and may be a contributing factor to the development of angioedema | Bradykinin |
| Peptide causing increased capillary permeability and edema | Bradykinin and histamine |
| Dopamine (DA) agonist (for Parkinson's disease), used also for hyperprolactinemia | Bromocriptine |
| Dopamine agonist used in hyperprolactinemia | Bromocriptine |
| Ergot alkaloid that is a partial agonist at D2 receptors in the brain, used for patients who are refractory or cannot tolerate levodopa, causes erythromelalgia | Bromocriptine |
| Partial opioid agonist, considered a strong analgesic, has a long duration of action and is resistant to naloxone reversal | Buprenorphine |
| Heterocyclic antidepressants least likely to affect sexual performance, used for management of nicotine withdrawal, SE's include dizziness, dry mouth, aggravation of psychosis, and seizures | Bupropion |
| Agent that is a partial agonist for the 5-HT1A receptor | Buspirone |
| Drug of choice for generalized anxiety disorder, NOT effective in acute anxiety | Buspirone |
| Withdrawal from this drug causes lethargy, irritability, and headache | Caffeine |
| Used intranasally and decreases bone resorption | Calcitonin (salmon prep) |
| Used especially in postmenopausal women, dosage should be 1500 mg | Calcium |
| Loops lose and thiazide diuretics retain | Calcium |
| Block L-type calcium channel | Calcium channel blockers |
| MOA of class IV antiarrhythmics | Calcium channel blockers |
| MOA for Ethosuximide | Calcium channels |
| Drug causing depletion of substance P (vasodilator) | Capsaicin |
| Anti-seizure drugs used also for Trigeminal neuralgia | Carbamazepine |
| Anti-seizure agent that induces formation of liver drug-metabolism enzymes, is teratogen and can cause craniofacial anomalies and spina bifida | Carbamazepine |
| Anti-seizure drugs used as alternative drugs for mood stabilization | Carbamazepine, gabapentin, lamotrigine, and valproic acid |
| PCN active against pseudomonas | Carbenicillin, piperacillin and ticarcillin |
| This is combined with L-dopa, inhibits DOPA decarboxylase (active only peripherally) which allows lower effective doses of L-dopa and allows for fewer SE's (GI distress, postural hypotension, and dyskinesias) | Carbidopa |
| Agent similar to cisplatin, less nephrotoxic, but greater myelosuppression | Carboplatin |
| Lithium is associated with this congenital defect | Cardiac anomalies and is contraindicated in pregnancy or lactation |
| Nitrosoureas with high lipophilicity, used for brain tumors | Carmustine (BCNU) and lomustine (CCNU) |
| Reason fluoroquinolones are contraindicated in children and pregnancy | Cartilage damage |
| Agent used in CHF that is a selective alpha and nonselective beta blocker | Carvedilol |
| Cephalosporins able to cross the BBB | Cefixime (2nd) and 3rd generation |
| Drug used for N. gonorrhea in females | Ceftriaxone |
| Cephalosporin causes kernicterus in neonates | Ceftriaxone or cefuroxime |
| Newer NSAIDs that selectively inhibit COX-2 | Celecoxib and rofecoxib |
| Drug that selectively inhibits COX 2 | Celecoxib, valdecoxib, and rofecoxib |
| Class of antibiotics that have 10% cross sensitivity with penicillins | Cephalosporins |
| SE of tPA | Cerebral hemorrhage |
| This agent used to treat dry mouth in Sjögren's syndrome | Cevimeline |
| Readily detected markers that may assist in diagnosis of the cause of a drug overdose include | Changes in heart rate, blood pressure, respiration, body temperature, sweating, bowel signs, and pupillary responses |
| Major SE of bisphosphonates | Chemical esophagitis |
| Drug that causes gray baby syndrome and aplastic anemia | Chloramphenicol |
| Longer acting benzodiazepines used in the management of withdrawal states of alcohol and other drugs | Chlordiazepoxide and Diazepam |
| 1st generation antihistamine that is least sedating | Chlorpheniramine or cyclizine |
| Sulfonylurea NOT recommended for elderly because of very long half life | Chlorpropamide |
| First generation sulfonylurea | Chlorpropamide, tolbutamide, tolazamide, etc. |
| During Phase I these agents worsen the paralysis by succinylcholine, but during phase II they reverse the blockade produced by succinylcholine | Cholinesterase inhibitors |
| Reversal of blockade by neuromuscular blockers | Cholinesterase inhibitors |
| Chemical antagonists that bind to the inhibitor of ACh Estrace and displace the enzyme (if aging has not occurred) | Cholinesterase Regenerators |
| H2 blocker that causes the most interactions with other drugs | Cimetidine |
| Inhibitors of CYP450 | Cimetidine, ketoconazole, erythromycin, isoniazid and grapefruit |
| Toxicities include nephrotoxicity and ototoxicity, leading to a severe interaction with aminoglycosides | Cisplatin |
| Except for these agents all SSRI have significant inhibition of CytP450 enzymes | Citalopram and its metabolite escitalopram |
| Class of anti-arrhythmics that has a pro-arrhythmic effect (CAST trial), therefore are used as last line agents | Class IC (flecainide, propafenone, moricizine) |
| Beta blockers are used for which type of anginal attack | Classic |
| The ratio of the rate of elimination of a drug to its plasma concentration | Clearance (CL) |
| Drug notorious for causing pseudomembranous colitis | Clindamycin |
| Antiestrogen drugs used for fertility and breast cancer respectively | Clomiphene and tamoxifen |
| TCA used in obsessive compulsive disorder (OCD), most significant of TCA's for risk of seizure, weight gain, and neuropsychiatric signs and symptoms | Clomipramine |
| Example of three antidepressants that are indicated for obsessive compulsive disorder | Clomipramine, fluoxetine and fluvoxamine |
| Benzodiazepine that has efficacy against absence seizures and in anxiety states, such as agoraphobia | Clonazepam |
| Presynaptic Alpha 2 agonist used in HTN | Clonidine, and methyldopa |
| Effective in preventing TIA's | Clopidogrel and ticlopidine |
| Agent having no effect on D2 receptors, blocks D4, reserved for resistant schizophrenia, and can cause agranulocytosis | Clozapine |
| Anti-psychotic not shown to cause tardive dyskinesia | Clozapine |
| Regimen used for breast cancer | CMF (cyclophosphamide, methotrexate, and fluorouracil) and tamoxifen if ER+ |
| Additive effects when Sedative-Hypnotics used in combination with these agents | CNS depressants |
| Most important toxic effects of most local anesthetics | CNS toxicity |
| Local anesthetic with vasoconstrictive property, favored for head, neck, and pharyngeal surgery | Cocaine |
| Commonly abused LA which has cardiovascular toxicity including severe hypertension with cerebral hemorrhage, cardiac arrhythmias, and myocardial infarction | Cocaine |
| Overdoses of this agent with powerful vasoconstrictive action may result in fatalities from arrhythmias, seizures, respiratory depression, or severe HTN (MI and stroke) | Cocaine "super-speed" |
| These LA's have surface activity | Cocaine and benzocaine |
| Moderate opioid agonists | Codeine, hydrocodone, and oxycodone |
| Three C's associated with TCA toxicity | Coma, Convulsions, Cardiac problems (arrhythmias and wide QRS) |
| Constant low dose of estrogen and increasing dose of progestin for 21 days (last 5 days are sugar pills or iron prep) | Combination oral contraceptives (OC) |
| Ability to bind reversibly to the same site as the drug and without activating the effector system | Competitive antagonist |
| SE of CCB | Constipation, edema, and headache |
| Regimen used for non-Hodgkin's lymphoma | COP (cyclophosphamide, oncovin(vincristine), and prednisone) |
| Drugs that can be used for infantile spasms | Corticosteroids |
| Short acting GC's | Cortisone and hydrocortisone (equivalent to cortisol) |
| ACTH analog used for diagnosis of patients with corticosteroid abnormality | Cosyntropin |
| " | |
| Difference between COX 1 and COX 2 " | "COX 1 is found throughout |
| the body and COX 2 is only | |
| in inflammatory tissue" | |
| Plasma concentration of a drug at a given time | Cp |
| Product of proinsulin cleavage used to assess insulin abuse | C-peptide |
| SE of niacin | Cutaneous flush |
| Toxicity caused by nitroprusside and treatment | Cyanide toxicity treated with sodium thiosulfate |
| Agent for pernicious anemia | Cyanocobalamin (Vit B12) |
| Agent used for acute muscle spasm | Cyclobenzaprine |
| Anticancer drug also used in RA, produces acrolein in urine that leads to hemorrhagic cystitis | Cyclophosphamide |
| H1 blocker that is also a serotonin antagonist | Cyproheptadine |
| Anti-androgen used for hirsutism in females | Cyproterone acetate |
| T3 compound less widely used | Cytomel |
| DOC for malignant hyperthermia by acting on the sacroplasmic reticulum or skeletal muscle | Dantrolene |
| DOC for malignant hyperthermia that may be caused by use of halogenated anesthetics | Dantrolene |
| Drug used in neuroleptic malignant syndrome | Dantrolene |
| Drug of choice for leprosy | Dapsone |
| Most inhaled anesthetics SE | Decrease arterial blood pressure |
| MOA of metformin | Decreases hepatic glucose production and intestinal glucose absorption; increase insulin sensitivity |
| MOA of tetracycline | Decreases protein synthesis by inhibiting 30S ribosome |
| Antidote used for iron salt toxicity | Deferoxamine |
| Chelating agent used in acute iron toxicity | Deferoxamine |
| MOA of thrombolytics | Degradation of fibrin clots and are administered |
| Antivirals that are teratogens | Delavirdine, efavirenz, and ribavirin |
| Used for SIADH | Demeclocycline |
| Common mechanism by which overdose result in death | Depression of medullary and cardiovascular centers |
| SE of gold salts | Dermatitis of the mouth aplastic anemia and agranulocytosis |
| Pungent inhaled anesthetic which leads to high incidence of coughing and vasospasm | Desflurane |
| Synthetic analog of ADH hormone used for diabetes insipidus and nocturnal enuresis | Desmopressin (DDAVP) |
| ADH agonist used for pituitary diabetes insipidus | Desmopressin (DDAVP) |
| May protect against doxorubicin toxic by scavenging free radicals | Dexrazoxane |
| Amphetamine agents | Dextroamphetamines and methamphetamine |
| These agents are used as antitussive | Dextromethorphan, Codeine |
| Benzodiazepine with useful relaxant effects in skeletal muscle spasticity of central origin | Diazepam |
| DOC for status epilepticus | Diazepam |
| Facilitates GABA presynaptic inhibition | Diazepam |
| Agents having active metabolites, long half lives, and a high incidence of adverse effects | Diazepam, Flurazepam, chlordiazepoxide, and clorazepate |
| NSAID also available as an ophthalmic preparation | Diclofenac |
| Reduce transient hyper GI motility | Dicyclomine, methscopolamine |
| Anti-viral with a dose limiting toxicity of pancreatitis | Didanosine |
| Non-steroidal estrogen agonist causes clear cell adenocarcinoma of the vagina in daughters of women who used it during pregnancy | Diethylstilbestrol (DES) |
| Antidote for digoxin toxicity | Digibind |
| Antidote used for digitalis toxicity | Digibind (also need to d/c digoxin, normalize K+, and lidocaine if pt. Is arrhythmic) |
| Drug used supraventricular arrhythmias | Digoxin |
| H1 antagonist used in motion sickness | Dimenhydrinate, meclizine, and other 1st generation |
| Antidote for arsenic, mercury, lead, and gold poisoning | Dimercaprol |
| Antidote used for lead poisoning | Dimercaprol, EDTA |
| 1st generation antihistamine that is highly sedating | Diphendydramine |
| Prototype antagonist of H1 and H2 receptors | Diphenhydramine and impromidine respectively |
| These agents are used as antidiarrheal | Diphenoxylate, Loperamide |
| Prevents thrombosis in patients with artificial heart valve | Dipyridamole |
| Agent used in the treatment of alcoholism, if alcohol is consumed concurrently, acetaldehyde builds up and results in nausea, headache, flushing, and hypotension | Disulfiram |
| Agents that inhibit alcohol dehydrogenase | Disulfiram, metronidazole, certain sulfonylureas and cephalosporins |
| Metronidazole SE if given with alcohol | Disulfiram-like reaction |
| Beta 1 agonists used in acute CHF | Dobutamine and dopamine |
| 5ht-3 antagonist that has been associated with QRS and QTc prolongation and should not be used in patients with heart disease | Dolasetron |
| These agents are congeners of Amphetamine | DOM, STP, MDA, and MDMA "ecstasy" |
| Hormone inhibiting prolactin release | Dopamine |
| TCA with greatest sedation of this group, and marked antimuscarinic effects, used for sleep | Doxepin |
| Antipsychotics, reserpine at high doses, and MPTP (by-product of illicit meperidine analog) and is irreversible | Drug induced Parkinsonism |
| Angiotensin receptor blockers do NOT cause | Dry cough |
| SE of ACE inhibitors | Dry cough, hyperkalemia |
| Toxicity of organophosphate: | DUMBELSS (diarrhea, urination, miosis, bronchoconstriction, excitation of skeletal muscle and CNS, lacrimation, salivation, and sweating) |
| SE of Amiodarone | Dysfunction, photosensitivity, skin (blue smurf syndrome), Pulmonary fibrosis, thyroid and corneal deposits |
| Antiglaucoma organophosphate | Echothiophate |
| Median effective dose required for an effect in 50% of the population | ED50 |
| SE of Thiazolindinediones | Edema, mild anemia; interaction with drugs that undergo CytP450 3A4 metabolism |
| Indirect-Acting ACh Agonist, alcohol, short DOA and used in diagnosis of myasthenia gravis | Edrophonium |
| Ability of drug to produce a biologic effect | Efficacy |
| Population group especially sensitive to side effects of antidepressants | Elderly patients |
| Inhaled anesthetics are myocardial depressants | Enflurane and halothane |
| Inhibitors of catechol-O-methyltransferase (COMT), used as adjuncts in Parkinson's dx and cause acute hepatic failure (monitor LFT's) | Entacapone and Tolcapone |
| Long acting sympathomimetic, sometimes used to improve urinary continence in children and elderly with enuresis | Ephedrine |
| This is the drug of choice for anaphylactic shock | Epinephrine |
| Nonselective alpha agonists that increases outflow, probably via the uveoscleral veins | Epinephrine, dipivefrin |
| Agents for reduction of postpartum bleeding | Ergonovine and ergotamine |
| DOC for Legionnaires' disease | Erythromycin |
| Agent used for anemias associated with renal failure | Erythropoietin |
| Antidote used for beta agonist toxicity (eg. Metaproterenol) | Esmolol |
| This parenteral beta blocker is a short acting | Esmolol |
| Used intravenously for acute arrhythmias during surgery | Esmolol |
| Slightly increased risk of breast cancer, endometrial cancer, heart disease (questionable), has beneficial effects on bone loss | Estrogen |
| Used for prevention of postmenopausal osteoporosis in women | Estrogen (HRT-Hormone replacement therapy) |
| Antidote used for methanol and ethylene glycol | Ethanol |
| Agent with zero-order kinetics | Ethanol |
| Agent that is metabolized to acetaldehyde by alcohol dehydrogenase and microsomal ethanol-oxidizing system (MEOS) | Ethanol |
| These agents are CNS depressants | Ethanol, Barbiturates, and Benzodiazepines |
| Estrogen mostly used in oral contraceptives (OC) | Ethinyl estradiol and mestranol |
| Drugs of choice for absence seizures | Ethosuximide and valproic acid |
| Only bisphosphonates available IV | Etidronate |
| Bisphosphonates that cannot be used on continuous basis because it caused osteomalacia | Etidronate |
| The most important sign of withdrawal syndrome | Excessive CNS stimulation (seizures) |
| New class of drugs that works by inhibiting absorption of intestinal cholesterol and can be given concurrently with the Statins | Ezetimibe (Zetia) |
| Opioid associated with respiratory depression, but is used in high risk patients who may not survive full general anesthetia | Fentanyl |
| Opioid available trans-dermally | Fentanyl |
| Agent to treat hypochromic microcytic anemias | Ferrous sulfate |
| 2nd generation antihistamines | Fexofenadine, loratadine, and cetirizine |
| 5 alpha-reductase inhibitor used for benign prostatic hyperplasia (BPH) and male pattern baldness | Finasteride (Proscar and Propecia respectively) |
| Generation of antihistamine that has the most CNS effects | First generation due to being more lipid-soluble |
| Constant percentage of substrate metabolized per unit time | First order kinetics |
| The elimination of drug that occurs before it reaches the systemic circulation | First pass effect |
| SE of AGI's | Flatulence (do not use beano to tx), diarrhea, abdominal cramps |
| Mineralocorticoids | Fludrocortisone and deoxycorticosterone |
| Antidote used for benzodiazepine toxicity | Flumazenil |
| Antidote to benzodiazepine overdose (antagonist that reverses the CNS effects) | Flumazenil |
| Benzodiazepine receptor antagonist, it accelerates recovery from benzodiazepine overdose | Flumazenil |
| "Date rape drug" | Flunitrazepam (rohypnol) |
| Toxic to the liver, kidney, lungs, bone marrow, peripheral nerves, and cause brain damage in animals, sudden death has occurred following inhalation | Fluorocarbons and Industrial solvents |
| SSRI with long T1/2 and can be administered once weekly for maintenance, not acute tx | Fluoxetine |
| SSRI's less likely to cause a withdrawal syndrome | Fluoxetine |
| SSRI indicated for premenstrual dysphoric disorder | Fluoxetine (Sarafem) |
| Anti-psychotics available in depot preparation | Fluphenazine and haloperidol |
| Anti-androgen used for prostate cancer | Flutamide (Eulexin) |
| Agent used for megaloblastic anemia (but does NOT reverse neurologic symptoms) and decrease neural tube defects during pregnancy | Folic acid |
| Drug that inhibits alcohol dehydrogenase and is used in ethylene glycol exposure | Fomepizole |
| Ability of a drug to produce 100% of the maximum response regardless of the potency | Full agonist |
| Anti-seizure drugs used also for pain of neuropathic orgin | Gabapentin |
| MOA for benzodiazepines and barbiturates | GABA-related targets |
| DOC for CMV retinitis | Ganciclovir |
| Antivirals associated with neutropenia | Ganciclovir, zidovudine, saquinavir, and interferon |
| GnRH antagonist with more immediate effects, used for infertility | Ganirelix |
| COX 2 inhibitors may have reduced risk of | Gastric ulcers and GI Bleeding |
| Agent used neutropenia especially after chemotherapy | G-CSF (filgrastim) and GM-CSF (sargramostim) |
| Methyldopa is contraindicated in | Geriatrics due to its CNS (depression) effects |
| Pneumonic for 3 zones of adrenal cortex | GFR |
| SE of Aspirin | GI bleeding |
| SE of phenytoin | Gingival hyperplasia |
| SE of phenytoin | Gingival hyperplasia, nystagmus, diplopia and ataxia |
| Ultra long acting insulin, has over a day duration of action | Glargine (Lantus) |
| Epinephrine and dipivefrin are used for | Glaucoma |
| 3 zones of adrenal cortex and their products | Glomerulosa (mineralocorticoids), fasciculata (glucocorticoid |
| Antidote for beta-blockers and hypoglycemia | Glucagon |
| Hyperglycemic agent that increases cAMP and results in glycogenolysis, gluconeogenesis, reverses hypoglycemia, also used to reverse severe beta-blocker overdose and smooth muscle relaxation | Glucagon |
| Used for Addison's disease, Congenital Adrenal Hyperplasia (CAH), inflammation, allergies, and asthma (as a local inhalation) | Glucocorticoids |
| Products of Phase II conjugation | Glucuronate, acetic acid, and glutathione sulfate |
| Important in synthesis of glucose to glycogen in the liver | GLUT 2 |
| Important in muscle and adipose tissue for glucose transport across muscles and TG storage by lipoprotein lipase activation | GLUT 4 |
| Drugs available in combination with metformin | Glyburide, glipizide, and rosiglitazone |
| Second generation sulfonylurea | Glyburide, glipizide, glimepiride, etc. |
| SE seen only in men with administration of ketoconazole | Gynecomastia |
| Common SE of spironolactone | Gynecomastia and hyperkalemia |
| SE of spironolactone | Gynecomastia hyperkalemia, and impotence |
| Time it takes for amount of drug to fall to half of its value, constant in first order kinetics (majority of drugs) | Half-life (T1/2) |
| SE of ergot alkaloids | Hallucinations resembling psychosis |
| Agent more frequently associated with extrapyramidal side effects that can be treated with benzodiazepine, diphenhydramine or muscarinic blocker | Haloperidol |
| Antipsychotic having the weakest autonomic effects | Haloperidol |
| Agents used in Tourette's dx | Haloperidol or pimozide |
| Inhaled anesthetic that may sensitize the myocardium to arrhythmogenic effects of catecholamines and has produced hepatitis | Halothane |
| Inhaled anesthetics metabolized by liver enzymes which has a major role in the toxicity of these agents | Halothane and methoxyflurane |
| Anticoagulant of choice in pregnancy | Heparin |
| SE of heparin | Heparin induced thrombocytopenia (HIT) |
| Main route of metabolism for benzodiazepines | Hepatic |
| Most frequent route of metabolism | Hepatic enzymes |
| Reason troglitazone was withdrawn from market | Hepatic toxicity |
| SE of acetaminophen | Hepatotoxicity |
| Most commonly abused in health care professionals | Heroin, morphine, oxycodone, meperidine and fentanyl |
| Prototype ganglion blocker | Hexamethonium |
| Drug with a high margin of safety | High therapeutic index |
| Common SE of tamoxifen and raloxifene | Hot flashes |
| Direct vasodilator of arteriolar smooth muscle | Hydralazine |
| Prevention of cyclophosphamide induced hemorrhagic cystitis | Hydration and mercaptoethanesulfonate (MESNA) |
| Interferes with activity of T-lymphocytes | Hydroxychloroquine |
| Anti-malarial drug used in rheumatoid arthritis (RA) | Hydroxychloroquine |
| Antihistamine that can be used for anxiety and insomnia and is not addictive | hydroxyzine (Atarax) |
| This may antagonize activity of local anesthetics | Hypercalcemia |
| This may enhance activity of local anesthetics | Hyperkalemia |
| Side effects occuring in antipsychotics that block dopamine | Hyperprolactinemia, menorrhea, galactorrhea, confusion, mood changes, decreased sexual interest, and weight gain |
| Alpha 1 agonist toxicity | Hypertension |
| Condition will result from in combination of MAOI with tyramine containing foods (ex. wine, cheese, and pickled meats) | Hypertensive crisis |
| SE of minoxidil | Hypertrichosis |
| SE of thiazide (HCTZ) diuretics | Hyperuricemia, hypokalemia and hyperglycemia |
| SE of loop (furosemide) diuretics | Hyperuricemia, hypokalemia and ototoxicity |
| Major SE of insulin | Hypoglycemia |
| Common SE of sulfonylureas, repaglinide, and nateglinide | Hypoglycemia |
| Digoxin toxicity can be precipitated by | Hypokalemia |
| Routes of administration of heparin | IM (only LMW) and IV |
| TCA used in chronic pain, enuresis, and ADD | Imipramine |
| Major nutritional side effect of bile acid-binding resins | Impair absorption of fat soluble vitamin absorption (A,D,E,K) |
| Barbiturates MOA | Increase the DURATION of GABA-mediated chloride ion channels |
| "MOA for benzodiazepines | |
| " | increase the FREQUENCY of GABA-mediated chloride ion channel opening |
| Major drug interaction with Quinidine | Increases concentration of Digoxin |
| Shock due to septicemia or myocardial infarction is made worse by | Increasing afterload and tissue perfusion declines |
| MOA of Cardiac glycosides (eg. digoxin) | Indirectly increase intracellular calcium and cardiac contractility by inhibit Na+/K+ ATPase |
| Agent used for closure of patent ductus arteriosus | Indomethacin |
| NSAIDS used in gout | Indomethacin and phenylbutazone |
| Atropine fever is the most dangerous effect and can be lethal in this population group | Infants |
| Contraindications to use of atropine | Infants, closed angle glaucoma, prostatic hypertrophy |
| Proteins that prevent action of tumor necrosis factor alpha (TNF-alpha) | Infliximab and etanercept |
| These drugs strongly potentiate and prolong effect of neuromuscular blockade (NMB) | Inhaled anesthetics, especially isoflurane, aminoglycosides, and antiarrhythmic |
| Drug or foods (grapefruit juice) that increase statin effect | Inhibit Cytochrome P450 3A4 |
| MOA of sulfonamides | Inhibit dihydropteroate synthase |
| MOA of quinolones | Inhibit DNA gyrase |
| MOA of thiazide diuretics | Inhibit Na+/Cl- cotransport |
| " | |
| MOA of corticosteroids" | inhibit phospholipase A2 |
| MOA of NSAIDS | inhibit prostaglandin synthesis by inhibiting cyclo-oxygenase (cox) |
| MOA of Leflunomide (newer agent) | Inhibiting Dihydroorotate Dehydrogenase which leads to decreased pyrimidine synthesis |
| MOA of erythromycin | Inhibition of protein synthesis at the 50s subunit of ribosome |
| inhibits HMG COA reductase | |
| MOA of loop diuretics | inhibits Na+/K+/2Cl- cotransport |
| MOA of Bisphosphonates | Inhibits osteoclast bone resorption |
| MOA of sildenafil (Viagra) | Inhibits phosphodiesterase-5, enhancing effects of nitric oxide-activated increases in cGMP |
| PTU (propylthiouracil) MOA | Inhibits thyroid hormone synthesis by blocking iodination of the tyrosine residues of thyroglobulin |
| MOA utilizes transmembrane receptors | Insulin |
| MOA of both generations | Insulin release from pancreas by modifying K+ channels |
| MOA of repaglinide | Insulin release from pancreas; faster and shorter acting than sulfonylurea |
| MOA of nateglinide | Insulin secretagogue |
| Used for hairy cell leukemia; it stimulates NK cells | Interferon alpha |
| Treatment of patients with prior episodes of thrombocytopenia after a cycle of cancer chemotherapy | Interleukin 11 (oprelvekin) |
| Can be effective for short term therapy of thyroid storm, but after several weeks of therapy causes an exacerbation of hyperthyroidism | Iodide salts |
| Radio contrast media that inhibits the conversion of T4 to T3 | Ipodate |
| Muscarinic antagonist used in asthma | Ipratropium |
| Bronchodilation in asthma and COPD | Ipratropium |
| MOA of aspirin | Irreversibly blocking cyclooxygenase |
| Beta cells are found | Islets of Langerhans |
| Inhaled anesthetic causes peripheral vasodilation | Isoflurane |
| This route is associated with rapid tolerance and psychologic dependence | IV administration |
| Drugs of choice for status epilepticus | IV diazepam or phenytoin (for prolonged therapy not acute) |
| This produces "dissociative anesthesia", is a cardiovascular stimulant which may increases intracranial pressure, and hallucinations occur during recovery | Ketamine |
| Agents used in treatment of carcinoid tumor | Ketanserin cyproheptadine, and phenoxybenzamine |
| 5HT2 antagonist mediate synaptic excitation in the CNS and smooth muscle contraction | Ketanserin, cyproheptadine, and ergot alkaloids (partial agonist of alpha and serotonin receptors) |
| Antifungal agent used for inhibition of all gonadal and adrenal steroids | Ketoconazole |
| NSAID available orally, IM and ophthalmically | Ketoralac |
| NSAID that is used for acute condition, such as pre-op anesthesia and has limited duration (<5 days) of use due to nephrotoxicity | Ketoralac |
| SE of colchicine | Kidney and liver toxicity |
| Major route of elimination for Lithium | Kidneys |
| Combined alpha and beta blocking agents that may have application in treatment of CHF | Labetalol and carvedilol |
| Most important potential SE of metformin | Lactic acidosis |
| Converts asparagine to aspartate and ammonia, denies cancer cells of essential AA (asparagine) | L-asparaginase |
| Dose which is lethal to 50% of the population | LD50 |
| Agent used in drug therapy of Parkinson's instead of Dopamine which has low bioavailability and does not cross the BBB | L-dopa |
| Alternative anticoagulant used if HIT develops | Lepirudin |
| Antidote for methotrexate toxicity | Leucovorin |
| GnRH agonist used for infertility or different types of CA depending on pulsatile or steady usage respectively | Leuprolide |
| Drug is used with testosterone for male fertility | Leuprolide |
| Anti-Parkinson's drug which increases intraocular pressure and is contraindicated in closed angle glaucoma | Levodopa |
| Monitoring parameter to obtain before initiation of STATINS | LFT's |
| DOC for management of acute Ventricular arrhythmias | Lidocaine |
| Fibrates (gemfibrozil) increase activity of | Lipoprotein lipase |
| Very rapid acting insulin, having fastest onset and shortest duration of action | Lispro (Humalog) |
| DOC for bipolar affective disorder | Lithium |
| Patients being treated with lithium, who are dehydrated, or taking diuretics concurrently, could develop | Lithium toxicity |
| Exogenous insulin | Little C-peptide |
| Barbiturates decrease the effectiveness of many other drugs via this pharmacokinetics property | Liver enzyme INDUCTION |
| Major SE of zileuton | Liver toxicity |
| SE of mirtazapine | Liver toxicity, increased serum cholesterol |
| Target plasma concentration times (volume of distribution divided by bioavailability) | Loading dose (Cp*(Vd/F)) |
| Constant proportion of cell population killed rather than a constant number | Log-kill hypothesis |
| Associated with an increased incidence of cataracts in patients treated for glaucoma | Long acting cholinesterase inhibitors |
| Treatment of withdrawal syndrome involves | Long-acting sedative-hypnotic or a gradual reduction of dose, clonidine or propranolol |
| Benzodiazepine that undergo extrahepatic conjugation (which are useful in older or hepatically impaired) | Lorazepam, oxazepam, and temazepam |
| Orthostatic hypotension and QT prolongation | Low potency and risperidone |
| Drug with a narrow margin of safety | Low therapeutic index |
| Reduced seizure threshold | Low-potency typical antipsychotics and clozapine |
| Ergot alkaloid used as an illicit drug | LSD |
| Most widely used thyroid drugs such as Synthroid and Levoxyl contain | L-thyroxine (T4) |
| SE of hydralazine | Lupus-like syndrome |
| SE of procainamide | Lupus-like syndrome |
| Antidote useful for some drug induced Torsade de pointes | Magnesium sulfate |
| Agent to treat torsades de pointes | Magnesium sulfate |
| Concentration in the plasma times (clearance divided by bioavailability) | Maintenance dose (Cp*(CL/F)) |
| Osmotic diuretic used for increased intracranial pressure | Mannitol |
| Antidepressant associated with seizures and cardiotoxicity | Maprotiline |
| THC is active ingredient, SE's include impairment of judgment, and reflexes, decreases in blood pressure and psychomotor performance occur | Marijuana |
| MOA action of cromolyn | Mast cell stabilizer |
| Important drug interaction with chloral hydrate | May displace coumadin from plasma proteins |
| Alkylating agent, vesicant that causes tissue damage with extravasation | Mechlorethamine |
| MOPP regimen used in Hodgkin's disease (HD) | Mechlorethamine+ oncovorin (vincristine)+ procarbazine, and prednisone |
| Anemia caused by trimethoprim | Megaloblastic anemia |
| System that increases in activity with chronic exposure and may contribute to tolerance | MEOS |
| All opioids except this agent (which has a muscarinic blocking action) cause pupillary constriction | Meperidine |
| Use of this opioid with MAOI can lead to hyperpyrexic coma, and with SSRI's can lead to serotonin syndrome | Meperidine |
| Biguanide | Metformin |
| Opioid used in the management of withdrawal states | Methadone |
| Treatment for opioid addiction | Methadone, followed by slow dose reduction |
| Penicillins active against penicillinase secreting bacteria | Methicillin, nafcillin, and dicloxacillin |
| Thioamide agents used in hyperthyroidism | Methimazole and propylthiouracil (PTU) |
| Causes bone marrow suppression | Methotrexate |
| Fluoride released by metabolism of this inhaled anesthetic may cause renal insufficiency | Methoxyflurane |
| Organophosphate anthelmintic agent with long DOA | Metrifonate |
| DOC for tx of pseudomembranous colitis | Metronidazole |
| DOC for giardia, bacterial vaginosis, pseudomembranous colitis, and trichomonas | Metronidazole |
| Used for Cushing's syndrome (increased corticosteroid) and sometimes for adrenal function test | Metyrapone |
| "Benzodiazepine that is used for anesthesia | |
| " | Midazolam |
| Benzodiazepine used adjunctively in anesthesia | Midazolam |
| Chronic orthostatic hypotension can be treated with | Midodrine |
| Antiprogestin used as potent antagonist of GC receptor | Mifepristone |
| Anti-progesterone used as abortifacient | Mifepristone (RU-486) |
| Inversely related to potency of anesthetics | Minimum alveolar anesthetic concentration (MAC) |
| Oral antibiotic of choice for moderate inflammatory acne | Minocycline |
| Arterial vasodilator that works by opening K+ channels | Minoxidil |
| Tolerance to all effects of opioid agonists can develop except | Miosis and constipation |
| Antidepressant with MOA as alpha 2 antagonist, has effects on both 5-HT and NE, blocks histamine receptors, and is sedating | Mirtazapine |
| Non-depolarizing antagonist has short duration | Mivacurium |
| Most useful in patients with significant anxiety, phobic features, hypochondriasis, and resistant depression | Monamine oxidase inhibitors |
| Opioid that can be given PO, by epidural, and IV, which helps to relieve the dyspnea of pulmonary edema | Morphine |
| Opioids used in anesthesia | Morphine and fentanyl |
| Strong opioid agonists | Morphine, methadone, meperidine, and fentanyl |
| Receptors for serotonin (5HT-1) are located | Mostly in the brain, and they mediate synaptic inhibition via increased K+ conductance |
| Agents may exacerbate tardive dyskinesias (may be irreversible and there is no treatment) | Muscarinic blockers |
| Potassium sparing diuretics inhibit | Na+/K+ exchange |
| Antidote for acetaminophen toxicity | N-acetylcysteine |
| Antidote used for acetaminophen (APAP) toxicity | N-acetylcysteine (Mucomyst) |
| This beta blocker is the longest acting | Nadolol |
| Opioid antagonist that is given IV and had short DOA | Naloxone |
| This agent may cause more severe, rapid and intense symptoms to a recovering addict | Naloxone |
| Antidote used for opioid toxicity | Naloxone (IV), naltrexone (PO) |
| Opioid antagonist that is given orally in alcohol dependency programs | Naltrexone |
| Anabolic steroid that has potential for abuse | Nandrolone and stanozolol |
| Amino acid derivative | Nateglinide |
| Most common SE of fibrates | Nausea |
| Antidepressant which is inhibitor of CYP450 enzymes and may be associated with hepatic failure | Nefazodone |
| Carbamate with intermediate action postoperative and neurogenic ileus and urinary retention | Neostigmine |
| Common toxicities of cisplatin | Nephro and ototoxicity |
| Two toxicities of aminoglycosides | nephro and ototoxicity |
| Toxicity of amphotericin | Nephrotoxicity |
| Agent used in acutely decompensated CHF resembling natriuretic peptide | Nesiritide (Natrecor) |
| State of analgesia and amnesia produced when fentanyl is used with droperidol and nitrous oxide | Neuroleptanesthesia |
| Structurally related to acetylcholine, used to produce muscle paralysis in order to facilitate surgery or artifical ventilation. Full doses lead to respiratory paralysis and require ventilation | Neuromuscular blocking drugs |
| SE for ganciclovir | Neutro, leuko and thrombocytopenia |
| SE for ticlopidine | Neutropenia and agranulocytosis |
| Anti-viral agents associated with Stephen Johnson syndrome | Nevirapine, amprenavir |
| Decreases liver triglycerol synthesis | Niacin |
| W/D from this drug causes anxiety and mental discomfort | Nicotine |
| CCB with predominate effect on arteriole dilation | Nifedipine |
| Drug used in Chagas disease | Nifurtimox |
| Antidote used for cyanide poisoning | Nitrites |
| Nitrate used for acute anginal attacks | Nitroglycerin sublingual tablets |
| IV Drug used Hypertensive Crisis | Nitroprusside |
| Drug used in ergot alkaloids overdose, ischemia and gangrene | Nitroprusside |
| Inhaled anesthetic with a low blood/gas partition coefficient | Nitrous oxide |
| Inhaled anesthetics, less likely to lower blood pressure than other agents, and has the smallest effect on respiration | Nitrous oxide |
| Prolonged exposure to this inhaled anesthetic may lead to megaloblastic anemia | Nitrous oxide |
| Inhalant anesthetics | NO, chloroform, and diethyl ether |
| Ability to bind to either the same or different site as the drug | Noncompetitive antagonist |
| Tubocurarine is the prototype, pancuronium, atracurium, vecuronium are newer short acting agent, produce competitive block at end plate nicotinic receptor, causing flaccid paralysis | Nondepolarizing Neuromuscular Blockers |
| These prevent the action of Ach at the skeletal muscle endplate to produce a "surmountable blockade," effect is reversed by cholinesterase inhibitors (ex. neostigmine or pyridostigmine) | Nondepolarizing type antagonists |
| Prototypical drug is atropine | Nonselective Muscarinic Antagonists |
| Neurotransmitters affected by the action of antidepressants | Norepinephrine and serotonin |
| Endogenous insulin | Normal C-peptide |
| Secondary amines that have less sedation and more excitation effect | Nortriptyline, Desipramine |
| Class of drugs that reversibly inhibit COX | NSAIDS |
| Somatostatin (SRIF) analog used for acromegaly, carcinoid, glucagonoma and other GH producing pituitary tumors | Octreotide |
| DOC of chemo induced nausea and vomiting | Odansetron |
| Anti-emetics used in association with anti-cancer drugs that are 5-HT3 (serotonin receptor subtype ) antagonist | Odansetron, granisetron |
| Newer atypical antipsychotic used for bipolar disorder, known to cause weight gain, and adversely affect diabetes | Olanzapine |
| Newer atypical antipsychotics that also improve some of the negative symptoms and help acute agitation | Olanzapine, aripiprazole, and sertindole |
| Extrapyramidal dysfunction is more common with these agents, which block this subtype of dopamine receptor | Older antipsychotic agents, D2 receptors |
| Antipsychotics that reduce positive symptoms only | Older antipsychotics |
| "5HT-3 antagonist used in chemotherapeutic induced | |
| emesis " | "Ondansetron, granisetron, |
| dolasetron and alosetron " | |
| SE of these drugs include dependence, withdrawal syndrome, sedation, euphoria, respiratory depression nausea and vomiting, constipation, biliary spasm, increased ureteral and bladder tone, and reduction in uterine tone | Opioid Analgesics |
| Route of administration of warfarin | Oral |
| Nitrate used to prevent further attacks | Oral and transdermal forms of nitroglycerin |
| Treatment of resistant pseudomembranous colitis | ORAL vancomycin |
| Cause dizziness, tachycardia, hypotension, and flushing | Organic nitrites |
| Oral contraceptive available in a transdermal patch | Ortho-Evra |
| SE of alpha blockers | Orthostatic hypotension (especially with first dose) and reflex tachycardia |
| Some side effects of corticosteroids | Osteopenia, impaired wound healing, inc. risk of infection, inc. appetite, HTN, edema, PUD, euphoria, psychosis |
| Uses of bisphosphonates | Osteoporosis, Paget's disease, and osteolytic bone lesions, and hypercalcemia from malignancy |
| Aminoglycosides used with loop diuretics potentiate adverse effect | Ototoxicity |
| Leads to respiratory depression progressing to coma and death | Overdose of opioids |
| Different steps of Phase I | Oxidation, reduction, hydrolysis |
| Cystitis, postoperative bladder spasms, or incontinence | Oxybutynin, dicyclomine |
| Drug that causes contraction of the uterus | Oxytocin |
| Interact with microtubules (but unlike vinca which prevent disassembly of tubules), it stabilizes tubulin and cells remain frozen in metaphase | Paclitaxel (taxol) |
| Agent can blocking muscarinic receptors | Pancuronium |
| Some of SSRIs' therapeutic effects beside depression | Panic attacks, social phobias, bulimia nervosa, and PMDD premenstrual dysphoric disorder), OCD |
| The most toxic organophosphate | Parathion |
| SE of acetazolamide | Paresthesias, alkalization of the urine (which may ppt. Ca salts), hypokalemia, acidosis, and encephalopathy in patients with hepatic impairment |
| Ability to produce less than 100% of the response | Partial agonist |
| Treatments available for nicotine addiction | Patches, gum, nasal spray, psychotherapy, and bupropion |
| Most dangerous of the currently popular hallucinogenic drugs, OD leads to nystagmus, marked hypertension, and seizures, presence of both horizontal and vertical nystagmus is pathognomonic | PCP |
| Antidote used in poisonings: copper (Wilson's disease), lead, mercury, and arsenic | Penicillamine |
| Chelating agent used in Wilson's disease | Penicillamine |
| Methylxanthine derivative used as a remedy for intermittent claudication | Pentoxifylline |
| SE of INH | Peripheral neuritis and hepatitis |
| The most common neurologic abnormality in chronic alcoholics | Peripheral neuropathy (also excessive alcohol use is associated with HTN, anemia, and MI) |
| Used in pediatrics to maintain patency of ductus arteriosis | PGE1 |
| Approved for use in severe pulmonary HTN | PGI2 (epoprostenol) |
| This step of metabolism makes drug more hydrophilic and hence augments elimination | Phase I |
| DOC for febrile seizures | Phenobarbital |
| Nonselective alpha-blocking drug, long acting and irreversible, and used to treat pheochromocytoma. Blocks 5-HT, so occasionaly used for carcinoid tumor. Blocks H1 and used in mastocytosis | Phenoxybenzamine |
| Non-selective Alpha1blockers use to treat pheochromocytoma | Phenoxybenzamine |
| Nonselective alpha-blocking drug, short acting and reversible, used for rebound HTN from rapid clonidine withdrawal, and Raynaud's phenomena | Phentolamine |
| For rebound HTN from rapid clonidine withdrawal | Phentolamine |
| Alpha agonist used to produce mydriasis and reduce conjunctival itching and congestion caused by irritation or allergy, it does not cause cycloplegia | Phenylephrine |
| DOC for digoxin induced arrhythmias | Phenytoin |
| Anti-seizure agent that exhibits non-linear metabolism, highly protein bound, causes fetal hydantoin syndrome, and stimulates hepatic metabolism | Phenytoin |
| Enzyme which theophylline inhibits | Phosphodiesterase |
| Antidote used for anticholinergic poisoning | Physostigmine |
| Treatment of atropine overdose and glaucoma (because lipid soluable). Enters the CNS rapidly and has a stimulant effect, which may lead to convulsions | Physostigmine |
| Only direct acting agent that is very lipid soluble and used in glaucoma | Pilocarpine |
| Cholinomimetics that increase outflow, open trabecular meshwork, and cause ciliary muscle contraction | Pilocarpine, carbachol, physostigmine |
| Beta blockers partial agonist activity (intrinsic sympathomimetic activity) cause some bronchodilation and may have an advantage in treating patients with asthma | Pindolol and acebutolol |
| Thiazolidinediones | Pioglitazone, Rosiglitazone, Troglitazone (withdrawn/d from market) |
| Aspirin reduces mortality in unstable angina by | Platelet aggregation inhibition |
| Type of resistance found with vancomycin | Point mutation |
| SE of methyldopa | Positive Comb's test, depression |
| Activation of these receptors open K+ ion channels to cause membrane hyperpolarization | Postsynaptic Mu receptors |
| SE of nitrates | Postural hypotension, reflex tachycardia, hot flashes, and throbbing headache due to meningeal artery dilation |
| MOA of class III antiarrhythmics | Potassium channel blockers |
| Amount of drug necessary to elicit a biologic effect | Potency |
| Aspirin is contraindicated in children with viral infection | Potential for development of Reye's syndrome |
| This agent regenerates active cholinesterase and is a chemical antagonist used to treat organophosphate exposure | Pralidoxime |
| Used to treat patients exposed to insecticides such as parathion | Pralidoxime |
| Non ergot agents used as first-line therapy in the initial management of Parkinson's | Pramipexole and ropinirole |
| Alpha 1selective blockers | Prazosin, terazosin and doxazosin (-AZOSIN ending) |
| Selective Alpha 1 blocker used for hypertension, BPH, may cause first dose orthostatic hypotension | Prazosin, terazosin, doxazosin |
| Drug used in cancer therapy causes Cushing-like symptoms | Prednisone |
| Intermediate acting GC's | Prednisone, methylprednisolone, prednisolone, and triamcinolone |
| COX 2 inhibitors should be used cautiously in pts with | Pre-existing cardiac or renal disease |
| HMG CoA reductase inhibitors are contraindicated in | Pregnancy |
| Fibrates are contraindicated in | Pregnancy |
| Warfarin is contraindicated in | Pregnancy |
| Ace inhibitors are contraindicated in | pregnancy and with K+ |
| Activation of these receptors close Ca2+ ion channels to inhibit neurotransmitter release | Presynaptic mu, delta, and kappa receptors |
| LA causing methemoglobinemia | Prilocaine |
| Drug used in exoerythrocytic cycle of malaria | Primaquine |
| CCB are DOC for | Prinzmetal's angina |
| Agent used to treat chronic gout by increasing uric acid secretion | Probenecid and sulfinpyrazone |
| Produces disulfiram-like reaction with ethanol | Procarbazine |
| Alpha cells in the pancreas | Produce glucagon |
| Beta cells in the pancreas | Produce insulin |
| Delta cells in the pancreas | Produce Somatostatin |
| Specific pharmacokinetic characteristic of amiodarone | Prolonged half-life, up to six weeks |
| Side effect of sotalol | prolongs QT and PR interval |
| Limiting side effect of Quinidine | Prolongs QT interval |
| Produces both rapid anesthesia and recovery, has antiemetic activity and commonly used for outpatient surgery, may cause marked hypotension | Propofol |
| Weak opioid agonist, poor analgesic, its overdose can cause severe toxicity including respiratory depression, circulatory collapse, pulmonary edema, and seizures | Propoxyphene |
| This beta blocker is highly lipid soluble and may account for side effects such as nightmares | Propranolol |
| Non-selective Beta-blocker also used for migraine prophylaxis | Propranolol |
| Agent effective in physiologic and essential tremor | Propranolol |
| Prostaglandins that cause abortions | Prostaglandin E1 (misoprostol) PGE2, and PGF2alpha |
| This agent cause increased aqueous outflow | Prostaglandin PGF2a |
| Antidote used for heparin toxicity | Protamine |
| Antidote to reverse actions of heparin | Protamine sulfate |
| HIV antiviral class known to have severe drug interactions by causing inhibition of metabolism | Protease inhibitors |
| Chronic high dose abuse of nicotine leads to | Psychotic state, overdose causes agitation, restlessness, tachycardia, hyperthermia, hyperreflexia, and seizures |
| Thioamide less likely to cross placenta, inhibits peripheral conversion of T4 to T3 in high doses, and should be used with extreme caution in pregnancy | PTU |
| Thrombolytics are used for | Pulmonary embolism and DVT |
| Treatment with cancer chemotherapy at high doses every 3-4 weeks, too toxic to be used continuously | Pulse therapy |
| Treatment of myasthenia gravis | Pyridostigmine |
| Increased risk of developing cataracts | Quetiapine |
| Permanently cures thyrotoxicosis, patients will need thyroid replacement therapy thereafter. Contraindicated in pregnancy | Radioactive iodine |
| Selective estrogen receptor modulator (SERM) used for prevention of osteoporosis and currently being tested for treatment of breast cancer (Stars study) | Raloxifene |
| Increase bone density, also being tested for breast CA tx. | Raloxifene (SERM-selective estrogen receptor modulator) |
| SE of clonidine | Rebound HTN, sedation, dry mouth |
| Common side effect of Rifampin | Red urine discoloration |
| Newer alpha 2 agonist (apraclonidine and brimonidine) treat glaucoma | Reduce aqueous synthesis |
| Sedative-Hypnotics action | Reduce inhibition, suppress anxiety, and produce relaxation |
| Often mixed with local anesthetic to | Reduce the loss from area of injection |
| Diuretics work in CHF by | Reducing preload |
| Beta blockers work in CHF by | Reducing progression of heart failure (never use in acute heart failure) |
| Rapid acting, crystalline zinc insulin used to reverse acute hyperglycemia | Regular (Humulin R) |
| MOA of nitrates | Relax vascular smooth muscle, at low doses dilate veins and at high doses dilate arterioles |
| Major effect of benzodiazepines on sleep at high doses | REM is decreased |
| Meglitinide | Repaglinide |
| Toxic effect of anticancer drug can be lessened by rescue agents | Rescue therapy |
| The most important cause of acute deaths in cholinesterase inhibitor toxicity | Respiratory failure |
| SE of hydroxychloroquine | Retinal destruction and dermatitis |
| Concurrent use of fibrates and statins increases risk of | Rhabdomyolysis |
| SE of HMG COA reductase inhibitors | Rhabdomyolysis and Hepatotoxicity |
| DMARDs are slow acting drugs for | Rheumatic disease |
| DOC for RSV | Ribavirin |
| Meningitis prophylaxis in exposed patients | Rifampin |
| Treatment for TB patients (think RIPE) | Rifampin, Isoniazid, Pyrazinamide, and Ethambutol |
| Antipsychotic used in the treatment of psychiatric symptoms in patients with dementia | Risperidone |
| Atypical antipsychotic causing high prolactin levels | Risperidone |
| Long acting beta 2 agonist used in asthma | Salmeterol |
| Longer acting Beta 2 agonists is recommended for prophylaxis of asthma | Salmeterol |
| Treatment of motion sickness | Scopolamine |
| Technique used to diagnose perianal itching, and the drug used to treat it | "Scotch tape technique |
| and mebendazole" | |
| Most common side effect of 1st generation antihistamines | Sedation |
| SE of imipenem | Seizures |
| MOA of Colchicine (used in acute gout) | Selective inhibitor of microtubule assembly |
| Inhibitor of MAO type B which metabolizes dopamine, used adjunct to levodopa or as sole agent in newly diagnosed pt's | Selegiline |
| GHRH analog used as diagnostic agent | Sermorelin |
| MAOI should not be administered with SSRI's or potent TCA's due to development of this condition | Serotonin syndrome |
| Antipsychotic that does not block muscarinic or histamine receptors, and it prolongs the QT interval | Sertindole |
| Laboratory value required to be monitored for patients on valproic acid | Serum ammonia and LFT's |
| Limiting adverse effect of ganglion blockade that patients usually are unable to tolerate | Severe hypertension |
| Side effect of Mitomycin | SEVERE myelosuppression |
| All antidepressants have roughly the same efficacy in treating depression, agents are chosen based on these criterion | Side-effect profile and prior pt response |
| Beta 1 agonist toxicity | Sinus tachycardia and serious arrhythmias |
| Beta 2 agonist toxicity | Skeletal muscle tremor |
| Distribution of histamine receptors H1, H2, and H3 | Smooth muscle; stomach, heart, and mast cells; nerve endings, CNS respectively |
| Antidote used for tricyclic antidepressants (TCA) | Sodium bicarbonate |
| Mechanisms of action for Phenytoin, Carbamazepine, Lamotrigine | Sodium blockade |
| MOA of class I A (eg. Procainamide), class IB (eg. Lidocaine), and class IC (eg. Flecainide) antiarrhythmics | Sodium channel blockers |
| Antidote for hyperkalemia | sodium polystyrene sulfonate (Kayexalate) |
| Somatotropin (GH) analog used in GH deficiency (dwarfism) | Somatrem |
| Antiarrhythmic that exhibits Class II and III properties | Sotalol |
| Agents acting in the CNS or in the skeletal muscle, used to reduce abnormally elevated tone caused by neurologic or muscle end plate disease | Spasmolytic drugs |
| Selectivity of a drug for its receptor | Specificity |
| Diuretic used to antagonize aldosterone receptors | Spironolactone |
| Diuretic used to treat primary aldosteronism | Spironolactone |
| Well-tolerated and are first-line antidepressants | SSRI's, bupropion, and venlafaxine |
| Disease caused by excess ergot alkaloids | St. Anthony's Fire |
| When the rate of drug input equals the rate of drug elimination | Steady state |
| Causes acne, premature closure of epiphyses, masculinization in females, hepatic dysfunction, MI, and increases in libido and aggression | Steroids |
| SE for Lamotrigine | Stevens-Johnson syndrome |
| MOA of thiazolindinediones | Stimulate PPAR-gamma receptor to regulate CHO and lipid metabolism |
| MOA and effect of nitric oxide | Stimulates cGMP which leads to vascular smooth muscle relaxation |
| Thrombolytic that can cause allergic reaction | Streptokinase |
| Aminoglycoside that is least ototoxic | Streptomycin |
| Only member of depolarizing neuromuscular blocker, causes fasciculation during induction and muscle pain after use | Succinylcholine |
| One depolarizing blocker that causes continuous depolarization and results in muscle relaxation and paralysis, xcuses muscle pain postoperatively and myoglobinuria may occur | Succinylcholine |
| Anti-biotic frequently used for chronic UTI prophylaxis | sulfamethoxazole/ trimethoprim |
| Anti-rheumatic agent also used for ulcerative colitis | Sulfasalazine |
| Anti-microbials that cause hemolysis in G6PD-deficient patients | Sulfonamides |
| Class of drugs that may cause cross-sensitivity with thiazide diuretics | Sulfonamides |
| Triptan available in parenteral and nasal formulation | Sumatriptan |
| " | |
| 5HT-1d agonist used for migraine headaches " | Sumatriptan, naratriptan, and rizatriptan |
| Drug used for African sleeping sickness | Suramin |
| Anti-estrogen used for estrogen receptor + breast cancer | Tamoxifen |
| A1a-selective blocker used for BPH | Tamsulosin (Flomax) |
| Median toxic dose required for a toxic effect in 50% of the population | TD50 |
| Beta 2 agonist used to suppress premature labor, but cardiac stimulatory effects may be hazardous to mother and fetus | Terbutaline |
| Lethal arrhythmias resulting from concurrent therapy with azole fungals (metabolized by CYP 3A4) and these antihistamines which inhibit the 3A4 iso-enzyme. | Terfenadine and astemizole (have been removed from the market) |
| Agents having higher sedation and antimuscarinic effects than other TCA's | Tertiary amines |
| Bleomycin+vinblastine+etoposide+cisplatin produce almost a 100% response when all agents are used for this neoplasm | Testicular cancer |
| Converted to more active form DHT by 5 alpha-reductase | Testosterone |
| Agents used in Huntington's Disease | Tetrabenazine (amine depleting drug), Haloperidol (antipsychotic) |
| Longer acting local anesthetics which are less dependent on vasoconstrictors | Tetracaine and bupivacaine |
| Drug causes teeth discoloration | Tetracycline |
| Drug increases the renal clearance hence decreases levels of lithium | Theophylline |
| Window between therapeutic effect and toxic effect | Therapeutic index |
| Site of action of loop diuretics | Thick ascending limb |
| Anti-thyroid drugs | Thioamides, iodides, radioactive iodine, and ipodate |
| Barbiturate used for the induction of anesthesia | Thiopental |
| IV barbiturate used as a pre-op anesthetic | Thiopental |
| Only phenothiazine not exerting antiemetic effects, can cause visual impairment due to retinal deposits, and high doses have been associated with ventricular arrhythmias | Thioridazine |
| Antipsychotic having the strongest autonomic effects | Thioridazine |
| SE of amrinone | Thrombocytopenia |
| Other side effects of Quinidine | Thrombocytopenic purpura, and CINCHONISM |
| Mechanism of action (MOA) utilizes intracellular receptors | Thyroid and steroid hormones |
| Antiplatelet drug reserved for patients allergic to aspirin | Ticlopidine |
| This beta blocker lacks local anesthetic activity (decreases protective reflexes and increases the risk of corneal ulceration) and used in treating glaucoma | Timolol |
| These Beta blockers decrease aqueous secretion | Timolol (nonselective), betaxolol (selective) |
| SE of salicylates | Tinnitus, GI bleeding |
| Thrombolytic used for acute MI and ischemic (non hemorrhagic) CVA | Tissue plasmin activator |
| Similar to clonidine and may cause hypotension | Tizanidine |
| Nitrate free intervals are needed due to | Tolerance |
| Occurs when sedative hypnotics are used chronically or at high doses | Tolerance |
| Topical DOC in impetigo | Topical mupirocin (Bactroban) |
| Newer estrogen receptor antagonist used in advanced breast cancer | Toremifene (Fareston) |
| Life threatening cardiac event that prolong QT leads to | Torsades de pointes |
| Antidepressant also used for sleep that causes priapism | Trazodone |
| SE of lithium | Tremor, sedation, ataxia, aphasia, thyroid enlargement, and reversible diabetes insipidus |
| Sedation is a common side effect of these drugs, they lower seizure threshold, uses include BAD, acute panic attacks, phobias, enuresis, and chronic pain and their overdose can be deadly | Tricyclic antidepressants (TCA) |
| Ganglionic blockers formerly used in HTN | Trimethaphan, and hexamethonium |
| Agent with long duration of action and is sost likely to cause histamine release | Tubocurarine |
| Long acting insulin | Ultralente (humulin U) |
| MOA of general anesthetics | Unclear, thought to increase the threshold for firing of CNS neurons |
| Removal of PCP may be aided | Urinary acidification and activated charcoal or continual nasogastric suction |
| Major indication for H1 receptor antagonist | Use in IgE mediated allergic reaction |
| Reason ergot alkaloids are contraindicated in pregnancy | Uterine contractions |
| Agent that inhibits hepatic metabolism, is hepatotoxic and teratogen that can cause neural tube defects and gastrointestinal distress | Valproic acid |
| Drug of choice for myoclonic seizures | Valproic acid |
| Drugs of choice for generalized tonic-clonic and partial seizures | Valproic acid and Phenytoin |
| Anti-seizure drugs used also for bipolar affective disorder (BAD) | Valproic acid, carbamazepine, phenytoin and gabapentin |
| Drug used for MRSA | Vancomycin |
| Antibiotic causing red-man syndrome, and prevention | "Vancomycin, infusion |
| at a slow rate and antihistamines" | |
| Almost all local anesthetics have this property and sometimes require the administration of vasoconstrictors (ex. Epinephrine) to prolong activity | Vasodilation |
| Antidepressant having stimulant effects similar to SSRI's and can increase blood pressure | Venlafaxine |
| Antidepressant inhibiting norepinephrine, serotonin, and dopamine reuptake | Venlafaxine |
| CCB contraindicated in CHF | Verapamil |
| Microtubule inhibitor that causes peripheral neuropathy, foot drop (eg. ataxia), and "pins and needles" sensation | Vincristine |
| Antidote used for warfarin toxicity | Vitamin and Fresh frozen plasma (FFP) |
| Agent used for neurological deficits in megaloblastic anemia | Vitamin B12 |
| Vitamin given with calcium to ensure proper absorption | Vitamin D |
| Antidote to reverse actions of warfarin | Vitamin K or fresh frozen plasma |
| Relates the amount of drug in the body to the plasma concentration | Volume of distribution (VD) |
| Vitamin K dependent anticoagulant | Warfarin (PT) |
| Site of action of thiazide diuretics | Work at early distal convoluted tubule |
| Allopurinol treats chronic gout by inhibiting | Xanthine oxidase |
| Selective Alpha 2 blocker used for impotence (controversial effectiveness) | Yohimbine |
| Pneumonic for beta receptors | You have 1 heart (Beta 1) and 2 lungs (Beta 2) |
| Inhibitor of leukotrienes (LTD4) receptors and used in asthma | Zafirlukast and montelukast |
| Drug elimination with a constant amount metabolized regardless of drug concentration | Zero order kinetics |
| Inhibitor of lipoxygenase | Zileuton |
| Syndrome of hypersecretion of gastric acid and pepsin usually caused by gastrinoma; it is associated with severe peptic ulceration and diarrhea | Zollinger-Ellison Syndrome |
| Good hypnotic activity with less CNS SE than most benzodiazepines | Zolpidem, zaleplon |
Created by:
HY90X
Popular USMLE sets